Intraocular Lens (IOL) Implants Market Report 2025

The intraocular lens (IOL) implants market size has grown strongly in recent years. It will grow from $4.71 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. Growth during the historic period was driven by an aging population, a rising prevalence of cataracts, increased awareness of eye health and care, greater adoption of monofocal intraocular lenses, and a surge in minimally invasive surgical procedures.

The intraocular lens (IOL) implants market size is expected to see strong growth in the next few years. It will grow to $6.51 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. Growth in the forecast period is expected to be driven by rising demand for premium intraocular lenses (IOLs), an increase in outpatient cataract procedures, wider adoption of femtosecond laser-assisted surgeries, supportive government initiatives for vision care, and improved access to eye care in emerging markets. Key trends anticipated include a shift toward toric and multifocal IOLs, continued advancements in surgical methods, the integration of artificial intelligence in ophthalmology, the development of light-adjustable lenses, and a growing preference for personalized vision correction solutions.

The increasing number of cataract surgeries is anticipated to drive the growth of the intraocular lens (IOL) implants market. Cataract surgery involves removing the eye’s cloudy natural lens and replacing it with an artificial intraocular lens to restore clear vision. The rise in cataract surgeries is mainly due to the aging population, as cataracts are more common in older adults, who are more prone to vision impairment requiring surgical treatment. Intraocular lens implants improve the outcomes of cataract surgery by substituting the clouded lens with a clear artificial one, resulting in sharper vision, reduced dependence on glasses, quicker recovery, and long-lasting visual stability. For example, a report from EyeWorld Magazine, a U.S.-based ophthalmology publication, noted that in 2022, approximately 9,750 cataract surgeons in the U.S. performed 4.6 million procedures, averaging 472 surgeries each. By 2030, it is projected that around 10,000 surgeons will conduct close to 600 surgeries annually. This trend highlights the growing demand for intraocular lens implants driven by the increasing number of cataract surgeries.

Key players in the intraocular lens implants market are concentrating on developing next-generation presbyopia-correcting lenses to improve visual results and reduce patients’ reliance on glasses. These advanced lenses are designed to restore clear vision at various distances - near, intermediate, and far - for individuals with presbyopia. They help minimize or eliminate the need for reading glasses or bifocals after cataract surgery, offering greater visual independence and enhancing quality of life. For instance, in June 2025, Johnson & Johnson, a U.S.-based pharmaceutical company, introduced the Tecnis Odyssey, a next-generation intraocular lens that provides clear vision across all distances and lighting conditions. This lens uses advanced optics combined with a unique diffractive surface to deliver continuous, high-contrast vision while reducing night-time visual disturbances such as halos and glare. This innovation aims to give cataract patients improved visual freedom and a better quality of life.

In January 2023, Bausch + Lomb Corporation, a U.S.-based eye health company, acquired AcuFocus Inc. for an undisclosed amount. This acquisition was intended to broaden Bausch + Lomb’s intraocular lens portfolio by incorporating AcuFocus’s small-aperture technology, particularly the IC-8 Apthera IOL, designed to better address the needs of cataract patients with presbyopia and mild corneal astigmatism. AcuFocus Inc. is a U.S.-based medical device firm specializing in developing innovative ophthalmic technologies, including small-aperture intraocular lenses for the treatment of presbyopia and cataracts.

Major players in the intraocular lens (iol) implants market are Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Appasamy Associates Private Limited, STAAR Surgical Company, Aurolab, Lenstec Inc., Rayner Intraocular Lenses Limited, Omni Lens Private Limited, Ophtec B.V., Hanita Lenses R.C.A Ltd., Shanghai Haohai Biological Technology Co. Ltd., Biotech Vision Care Pvt. Ltd., HumanOptics AG, Soleko S.p.A., Care Group Sight Solutions Private Limited, Cristalens Industrie SAS, SAV-IOL SA, Eyebright Medical Technology (Beijing) Co. Ltd., Eagle Optics Pvt. Ltd., SIFI S.p.A.

North America was the largest region in the intraocular lens (IOL) implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intraocular lens (IOL) implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the intraocular lens (IOL) implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intraocular lens (IOL) implants market consists of sales of monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, accommodative intraocular lenses, extended depth of focus (EDOF) intraocular lenses, and phakic intraocular lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The intraocular lens (IOL) implants market research report is one of a series of new reports that provides intraocular lens (IOL) implants market statistics, including the intraocular lens (IOL) implants industry global market size, regional shares, competitors with the intraocular lens (IOL) implants market share, detailed intraocular lens (IOL) implants market segments, market trends, and opportunities, and any further data you may need to thrive in the intraocular lens (IOL) implants industry. These intraocular lens (IOL) implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Intraocular lens (IOL) implants are artificial lenses surgically placed inside the eye to replace the natural lens, most commonly removed during cataract surgery. These implants help restore clear vision by focusing light directly onto the retina after the cloudy natural lens is extracted.

The primary types of intraocular lens implants include non-foldable and foldable lenses. Non-foldable lenses, typically made from polymethyl methacrylate (PMMA), are rigid and require larger incisions during surgery due to their inability to fold. IOLs are manufactured from a range of materials such as silicone, PMMA, hydrophilic acrylic, hydrophobic acrylic, and hybrid materials. These implants are used across various surgical techniques, including phacoemulsification, extracapsular cataract extraction (ECCE), small incision cataract surgery (SICS), and femtosecond laser-assisted procedures. Applications include cataract surgery, refractive surgery, presbyopia correction, and secondary IOL implantation. The main end users consist of hospitals, ambulatory surgical centers (ASCs), ophthalmology clinics, eye research institutes, and other healthcare settings.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.